Hannah Joseph Hospital IPO offers exposure to a growing multi specialty healthcare provider in Madurai. Explore IPO details, financials, industry outlook, and key risks before investing.
In recent months, India’s IPO market has continued to attract steady investor interest, particularly in sectors driven by structural demand such as healthcare, infrastructure, and consumer services. Healthcare IPOs, in particular, have gained traction as rising medical awareness, improving insurance penetration, and expanding hospital infrastructure fuel long term growth. Regional hospital chains and specialty healthcare providers are increasingly tapping the capital markets to fund capacity expansion and technology upgrades.
Against this backdrop, Hannah Joseph Hospital Limited is set to open its IPO on January 22, 2026. Below is a detailed overview of the company, its IPO details, financial performance, and industry outlook.
About Hannah Joseph Hospital Ltd.
Incorporated in 2011, Hannah Joseph Hospital Limited is a multi specialty healthcare provider based in Madurai, Tamil Nadu. The hospital operates on a 2 acre campus with modern infrastructure, including central air conditioning and water heating systems, and offers a combined bed capacity of 150 beds.
The hospital focuses on specialised healthcare services across Neurology, Cardiology, Psychiatry, and Trauma care. By combining clinical expertise with affordable treatment models, the company aims to address the growing demand for quality healthcare services in Tier II and Tier III cities.
Key Medical Services Offered
• Department of Neurosciences including Neurology and Neurosurgery
• Department of Cardio Sciences including Cardiology
• Department of Trauma Care covering Orthopaedics and Oral & Maxillofacial Surgery
• Department of Psychiatry
As of November 30, 2025, the hospital employs 364 professionals across medical, nursing, administrative, and support functions.
Hannah Joseph Hospital Ltd. IPO Details
Through the IPO, Hannah Joseph Hospital Ltd. plans to raise ₹42.00 crore via a fresh issue of equity shares. The proceeds will primarily be used to establish a Radiation Oncology Centre, strengthening the hospital’s oncology care capabilities, along with meeting general corporate requirements.
Important IPO Timeline
| Event | Date |
|---|---|
| IPO Open Date | January 22, 2026 |
| IPO Close Date | January 27, 2026 |
| Allotment Date | January 28, 2026 |
| Initiation of Refunds | January 29, 2026 |
| Credit of Shares to Demat | January 29, 2026 |
| Listing Date | January 30, 2026 |
| Cut off time for UPI mandate | 5 PM on January 27, 2026 |
Key IPO Details
| Particulars | Details |
|---|---|
| Face Value | ₹10 per share |
| Issue Price Band | ₹67 to ₹70 per share |
| Lot Size | 1,500 shares |
| Total Issue Size | 60,00,000 shares aggregating to ₹42 Cr |
| Fresh Issue | 60,00,000 shares |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE SME |
| Shareholding Pre Issue | 1,66,98,363 shares |
| Shareholding Post Issue | 2,26,98,363 shares |
Lot Size of Hannah Joseph Hospital IPO
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 2 | 3,000 | ₹2,10,000 |
| Retail (Max) | 2 | 3,000 | ₹2,10,000 |
| S HNI (Min) | 3 | 4,500 | ₹3,15,000 |
| S HNI (Max) | 9 | 13,500 | ₹9,45,000 |
| B HNI (Min) | 10 | 15,000 | ₹10,50,000 |
Hannah Joseph Hospital Ltd. Financials
The Hannah Joseph Hospital IPO is valued at a pre issue market capitalisation of ₹158.89 crore. As of September 30, 2025, the company reported a Return on Equity of 9.39 percent and a Return on Capital Employed of 10.41 percent. The hospital maintains a healthy EBITDA margin of over 27 percent, reflecting efficient operational performance.
Key Company Financials
| Period Ended | 30 Sep 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets (₹ Cr) | 104.58 | 99.29 | 89.97 | 92.14 |
| Total Income (₹ Cr) | 42.75 | 77.90 | 63.63 | 54.90 |
| Profit After Tax (₹ Cr) | 5.12 | 7.21 | 4.07 | 1.01 |
| EBITDA (₹ Cr) | 11.65 | 20.52 | 17.98 | 16.38 |
| Net Worth (₹ Cr) | 53.22 | 48.93 | 43.93 | 34.15 |
| Total Borrowing (₹ Cr) | 31.64 | 33.58 | 31.39 | 42.95 |
Competitive Strengths
• Strong expertise in neurosciences supported by specialised clinical infrastructure
• Advanced cardiac sciences with a focus on accurate diagnostics and patient outcomes
• Established trauma and orthopaedic care capabilities backed by experienced surgeons
• Robust emergency and critical care services operating round the clock
• Patient centred treatment approach focused on affordability and clinical quality
• Active community engagement and outreach programmes strengthening regional presence
Hannah Joseph Hospital Ltd.: Industry Outlook
• Rising healthcare demand in Tier II and Tier III cities driven by population growth and increasing medical awareness
• Government focus on strengthening healthcare infrastructure under national health initiatives
• Growing preference for specialty care hospitals offering focused medical expertise
• Increasing insurance penetration improving affordability of advanced treatments
• Long term demand tailwinds for oncology, neurology, and cardiac care services
Conclusion
Hannah Joseph Hospital Ltd. presents a healthcare focused investment opportunity anchored in specialised medical services and regional dominance in Madurai. The company benefits from stable operating margins, expanding healthcare demand, and plans to strengthen its oncology capabilities through IPO funded expansion. However, investors should consider risks such as regulatory compliance requirements, dependence on medical professionals, and sensitivity to regional healthcare demand before making an investment decision.
